Literature DB >> 8299900

Spasmolytic polypeptide: a trefoil peptide secreted by rat gastric mucous cells.

G P Jeffrey1, P S Oates, T C Wang, M W Babyatsky, S J Brand.   

Abstract

BACKGROUND/AIMS: Spasmolytic polypeptide (SP) is a trefoil peptide expressed in the digestive tract. This study aimed to determine the structure and distribution of SP expression in the rat gastrointestinal tract.
METHODS: The structure of rat SP was determined from the sequence of complementary DNAs isolated from antral RNA. SP gene expression was localized by Northern blotting and in situ hybridization in the adult and fetal rat digestive tract. Expression of the SP peptide was localized by immunocytochemistry and Western blot analysis.
RESULTS: SP messenger (m)RNA was found predominantly in the stomach with highest expression in the antrum. High levels of SP mRNA were expressed in the fetal stomach before gastrin and somatostatin expression. Surprisingly, SP mRNA and peptide did not colocalize in the gastric mucosa, SP mRNA being superficial to SP peptide immunoreactivity throughout the gastric mucosa. Abundant SP immunoreactivity was seen in the lumen of the gastric glands and the mucus layer adherent to the gastric mucosa, indicating luminal secretion.
CONCLUSIONS: In the rat, SP is a peptide secreted predominantly from antral mucous cell. The high concentrations of SP in the adherent gastric mucus layer (approximately 10 mumol/L) suggest that SP functions as a structural peptide rather than a regulatory peptide.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8299900     DOI: 10.1016/0016-5085(94)90590-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  32 in total

1.  The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach.

Authors:  J L Newton; A Allen; B R Westley; F E May
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

2.  The trefoil gene family are coordinately expressed immediate-early genes: EGF receptor- and MAP kinase-dependent interregulation.

Authors:  D Taupin; D C Wu; W K Jeon; K Devaney; T C Wang; D K Podolsky
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

3.  TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury.

Authors:  James J Farrell; Douglas Taupin; Theodore J Koh; Duan Chen; Chun-Mei Zhao; Daniel K Podolsky; Timothy C Wang
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

4.  Exploring the interplay of barrier function and leukocyte recruitment in intestinal inflammation by targeting fucosyltransferase VII and trefoil factor 3.

Authors:  P L Beck; E Ihara; S A Hirota; J A MacDonald; D Meng; N N Nanthakumar; D K Podolsky; R J Xavier
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-18       Impact factor: 4.052

5.  Anti-tumor efficacy evaluation of a novel monoclonal antibody targeting neutral amino acid transporter ASCT2 using patient-derived xenograft mouse models of gastric cancer.

Authors:  Noriyuki Kasai; Aya Sasakawa; Kenta Hosomi; Tze Wei Poh; Bernadette Lynn Chua; Wei Peng Yong; Jimmy So; Shing Leng Chan; Richie Soong; Koji Kono; Toshihiko Ishii; Kazuya Yamano
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

6.  Trefoil factor family-3 is associated with aggressive behavior of colon cancer cells.

Authors:  Xianyang Yio; Jie-yu Zhang; Mark Babyatsky; Anli Chen; Jing Lin; Qui-Xiang Fan; J Lawrence Werther; Steven Itzkowitz
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

7.  Goblet-cell-specific transcription of mouse intestinal trefoil factor gene results from collaboration of complex series of positive and negative regulatory elements.

Authors:  H Itoh; N Inoue; D K Podolsky
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

Review 8.  Structure, Function, and Therapeutic Potential of the Trefoil Factor Family in the Gastrointestinal Tract.

Authors:  Nayara Braga Emidio; Stuart M Brierley; Christina I Schroeder; Markus Muttenthaler
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-09

9.  Expression of trefoil peptides pS2 and human spasmolytic polypeptide in gastric metaplasia at the margin of duodenal ulcers.

Authors:  S Khulusi; A M Hanby; J M Marrero; P Patel; M A Mendall; S Badve; R Poulsom; G Elia; N A Wright; T C Northfield
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

Review 10.  Aspects of the biology of regeneration and repair in the human gastrointestinal tract.

Authors:  N A Wright
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1998-06-29       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.